Brain-Computer-Interface
FAQ's
Answer : According to Precedence Research, the global digital biomarkers market size was reached at US$ 1.57 billion in 2021 and is anticipated to surpass over US$ 14.58 billion by 2030.
Answer : The global digital biomarkers market is expected to drive growth at a CAGR of 28.1% from 2022 to 2030.
Answer : The global digital biomarkers market is primarily driven by the rising usage of the digital biomarkers across various applications such as diabetes, respiratory diseases, CVDs, and sleep disorders.
Answer : The major players operating in the digital biomarkers market are Bayer AG, Biogen Inc., ActigraphLLc, Amgen Inc, F. Hoffmann-La Roche Ltd, Fitbit Inc, GlaxoSmithKline Plc, Koninklijke Philips N.V., Mindstrong Health, Medical Care Corporation, Medopad Ltd.
Answer : Asia Pacific dominated the global digital biomarkers market, accounting for around 40% of the market share in 2020 and will lead the market in the near future.